Search by Drug Name or NDC

NDC 42291-0054-30 Fesoterodine Fumarate 8 mg/1 Details

Fesoterodine Fumarate 8 mg/1

Fesoterodine Fumarate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is FESOTERODINE FUMARATE.

MedlinePlus Drug Summary

Fesoterodine is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Fesoterodine is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles to prevent urgent, frequent, or uncontrolled urination.

Related Packages: 42291-0054-30
Last Updated: 04/07/2024
MedLinePlus Full Drug Details: Fesoterodine

Product Information

NDC	42291-0054
Product ID	42291-054_0995fc87-8581-8c9f-e063-6294a90ad91f
Associated GPIs
GCN Sequence Number	064001
GCN Sequence Number Description	fesoterodine fumarate TAB ER 24H 8 MG ORAL
HIC3	R1A
HIC3 Description	URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT
GCN	99712
HICL Sequence Number	035606
HICL Sequence Number Description	FESOTERODINE FUMARATE
Brand/Generic	Generic
Proprietary Name	Fesoterodine Fumarate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Fesoterodine Fumarate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	8
Active Ingredient Units	mg/1
Substance Name	FESOTERODINE FUMARATE
Labeler Name	AvKARE
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA205002
Listing Certified Through	2024-12-31

Package

NDC 42291-0054-30 (42291005430)

Pricing Information	N/A
NDC Package Code	42291-054-30
Billing NDC	42291005430
Package	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-054-30)
Marketing Start Date	2023-11-07
NDC Exclude Flag	N